Eli Lilly's Recent Acquisitions in Diverse Therapeutic Areas
Eli Lilly has made over $25 billion in acquisitions this year to diversify beyond metabolic medicine into areas like oncology and sleep disorders. Key deals include Kelonia Therapeutics for cell therapy advancements, potentially revolutionizing CAR-T treatments.
Tickers: $LLY
Topics: cell therapy diversification oncology pharmaceuticals